Evidence map

ArticleCardiovascular diabetology2019

The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats.

Hsiang-Chun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

110 papers cite itlatest 60 shown

2019
2021
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 30935417